Spyre Therapeutics to Offer 4.12M Firm Shares & Option for Up to 618K More in Public Offering
Spyre Therapeutics entered into an underwriting agreement to sell an aggregate of 4,117,648 shares of common stock, with an option for an additional 617,647 shares. The offering will be led by Jefferies LLC, TD Securities (USA) LLC, Leerink Partners LLC, and Stifel, Nicolaus & Company, Incorporated, facilitating capital raising for the company.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed